6-36676721-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001291549.3(CDKN1A):c.-142+151T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 151,986 control chromosomes in the GnomAD database, including 29,024 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 29024 hom., cov: 31)
Consequence
CDKN1A
NM_001291549.3 intron
NM_001291549.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.734
Publications
10 publications found
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.802 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKN1A | NM_001291549.3 | c.-142+151T>C | intron_variant | Intron 1 of 3 | NP_001278478.1 | |||
| CDKN1A | NM_001374509.1 | c.-50+151T>C | intron_variant | Intron 1 of 3 | NP_001361438.1 | |||
| CDKN1A | NM_001374510.1 | c.34+151T>C | intron_variant | Intron 1 of 2 | NP_001361439.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKN1A | ENST00000448526.6 | c.-38+197T>C | intron_variant | Intron 1 of 3 | 3 | ENSP00000409259.3 | ||||
| CDKN1A | ENST00000615513.4 | c.-6+197T>C | intron_variant | Intron 1 of 2 | 2 | ENSP00000482768.1 | ||||
| CDKN1A | ENST00000459970.1 | n.43+151T>C | intron_variant | Intron 1 of 2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.600 AC: 91101AN: 151866Hom.: 28955 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
91101
AN:
151866
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.600 AC: 91235AN: 151986Hom.: 29024 Cov.: 31 AF XY: 0.600 AC XY: 44604AN XY: 74284 show subpopulations
GnomAD4 genome
AF:
AC:
91235
AN:
151986
Hom.:
Cov.:
31
AF XY:
AC XY:
44604
AN XY:
74284
show subpopulations
African (AFR)
AF:
AC:
33520
AN:
41438
American (AMR)
AF:
AC:
9937
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
2115
AN:
3464
East Asian (EAS)
AF:
AC:
3623
AN:
5176
South Asian (SAS)
AF:
AC:
2366
AN:
4812
European-Finnish (FIN)
AF:
AC:
4719
AN:
10548
Middle Eastern (MID)
AF:
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33111
AN:
67962
Other (OTH)
AF:
AC:
1327
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1717
3433
5150
6866
8583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2128
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.